Advisory Board
South Australian immunoGENomics Cancer Institute (SAiGENCI) is overseen by an independent Advisory Board, comprising nominees of the Commonwealth Government, the University of ÐÂÀ˲ÊƱ and the Central ÐÂÀ˲ÊƱ Local Health Network.
The Board exists to set and monitor the strategy and policy direction for the Institute, to review and approve its activities and expenditure, and to support the University in meeting its obligations under the Commonwealth Funding Deed. Â
The Board is advisory in nature only. This resides within the overarching constraints implied by SAiGENCI's establishment as an academic unit linked to the University of ÐÂÀ˲ÊƱ’s Faculty of Health and Medical Sciences.